Capricor Therapeutics | CAPR - Equity Capital And Reserves


Capricor Therapeutics reported $305.79M in Equity Capital and Reserves for its fiscal quarter ending in December of 2025.





Equity Capital And Reserves Change Date
Alterity Therapeutics Limited AUD 36.21M 18.58M Dec/2025
Bioline Rx USD 19.53M 537K Sep/2025
Capricor Therapeutics USD 305.79M 221.92M Dec/2025
Cipla INR 329.19B 16.3B Sep/2025
Cytokinetics USD -659.62M 138.5M Dec/2025
Geron USD 225.87M 22.83M Dec/2025
Grifols EUR 6.21B 133.12M Dec/2025
Immunic USD 10.5M 23.41M Sep/2025
J&J USD 78.47B 0 Sep/2025
Plus Therapeutics USD 4M 1.06M Dec/2025
Prothena USD 280.47M 14.51M Dec/2025
PTC Therapeutics USD -205.31M 49.56M Dec/2025
Sarepta Therapeutics USD 1.14B 179.5M Dec/2025